LASP1 and chronic myelogenous leukemia, BCR-ABL1 positive: In order to identify potential LASP1‐mediated pathways and related factors that may help to further eradicate minimal residual disease (MRD), the effect of LASP1 on processes involved in progression and maintenance of CML was investigated.